سعر ابيكوبنتين 300 مجم 30 قرص 2024

Epicopentin 300 mg 30 caps.: gabapentin 300 mg capsules (EIPICO, Egypt).

• Epilepsy: adjunctive therapy of partial seizures with and without secondary generalization in adults and children aged 6 years and above; monotherapy of partial seizures with and without secondary generalization in adults and adolescents aged 12 years and above. Peripheral neuropathic pain such as painful diabetic neuropathy and post-herpetic neuralgia in adults (EIPICO product page).EIPICO (Egyptian International Pharmaceutical Industries Co.)
• US-labelled uses: management of postherpetic neuralgia in adults; adjunctive therapy of partial-onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy (US label).Population: Adults and pediatric patients ≥3 years as labeledDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions: postherpetic neuralgia — dizziness, somnolence and peripheral edema; epilepsy (>12 years) — somnolence, dizziness, ataxia, fatigue and nystagmus; epilepsy (3–12 years) — viral infection, fever, nausea and/or vomiting, somnolence and hostility (US label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to gabapentin or its ingredients (US label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Drug reaction with eosinophilia and systemic symptoms (DRESS)/multiorgan hypersensitivity, sometimes fatal, and anaphylaxis/angioedema have occurred; discontinue if no alternative cause is found (US label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Somnolence, sedation and dizziness may impair driving; patients should not drive until they know how the drug affects them (US label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Antiepileptic drugs increase the risk of suicidal thoughts or behavior; monitor patients. Abrupt or rapid discontinuation may increase seizure frequency (US label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Opioids and other CNS depressantsMajorConcomitant use may cause respiratory depression; monitor patients and adjust dosage as appropriate (US label).DailyMed (U.S. National Library of Medicine)
• Antacids containing aluminum and magnesium hydroxideMinorReduced gabapentin bioavailability by about 20% (about 10% when gabapentin was taken 2 hours after the antacid) (US label).DailyMed (U.S. National Library of Medicine)

• Published cohort data on gabapentin use in pregnancy have not indicated an increased risk of major birth defects or miscarriage, but have methodological limitations; developmental toxicity was seen in animals at clinically relevant doses. A pregnancy exposure registry (NAAED) exists (US label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Gabapentin is secreted in human milk; effects on the breastfed infant and on milk production are unknown — weigh benefits of breastfeeding against maternal need and potential infant risk (US label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.